These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32110804)

  • 21. lncRNA ARAP1-AS1 enhances proliferation and impairs apoptosis of lymphoma cells by sponging miR-6867-5p.
    Pang B; Gan Y; Wang J; Qu S
    Cancer Biomark; 2023; 38(3):333-342. PubMed ID: 37599524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA ARAP1-AS1 promotes tumorigenesis and metastasis through facilitating proto-oncogene c-Myc translation via dissociating PSF/PTB dimer in cervical cancer.
    Zhang Y; Wu D; Wang D
    Cancer Med; 2020 Mar; 9(5):1855-1866. PubMed ID: 31953923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA VCAN-AS1 promotes the malignant behaviors of breast cancer by regulating the miR-106a-5p-mediated STAT3/HIF-1α pathway.
    Du P; Luo K; Li G; Zhu J; Xiao Q; Li Y; Zhang X
    Bioengineered; 2021 Dec; 12(1):5028-5044. PubMed ID: 34365889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Non-Coding RNA ARAP1-AS1 Facilitates the Progression of Cervical Cancer by Regulating miR-149-3p and POU2F2.
    Zhou L; Xu XL
    Pathobiology; 2021; 88(4):301-312. PubMed ID: 33965958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
    Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
    Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
    [No Abstract]   [Full Text] [Related]  

  • 27. Up-regulated lncRNA AFAP1-AS1 indicates a poor prognosis and promotes carcinogenesis of breast cancer.
    Ma D; Chen C; Wu J; Wang H; Wu D
    Breast Cancer; 2019 Jan; 26(1):74-83. PubMed ID: 29974352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p.
    Zhou T; Lin K; Nie J; Pan B; He B; Pan Y; Sun H; Xu T; Wang S
    Pathol Res Pract; 2021 Jan; 217():153268. PubMed ID: 33246290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JHDM1D-AS1-driven inhibition of miR-940 releases ARTN expression to induce breast carcinogenesis.
    Zuo Y; Ma M; Wen Y; Chang L; Qu C
    Clin Transl Oncol; 2023 Jul; 25(7):2192-2203. PubMed ID: 36862282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer.
    Xu F; Li H; Hu C
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31127025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
    Pan W; Chen KJ; Huang YC
    Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long noncoding RNA HOXD-AS1 induces epithelial-mesenchymal transition in breast cancer by acting as a competing endogenous RNA of miR-421.
    Li Y; Han X; Li Q; Wang C; Lou Z; Wang X
    J Cell Biochem; 2019 Jun; 120(6):10633-10642. PubMed ID: 30730081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA FGD5-AS1 promotes colorectal cancer cell proliferation, migration, and invasion through upregulating CDCA7 via sponging miR-302e.
    Li D; Jiang X; Zhang X; Cao G; Wang D; Chen Z
    In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):577-585. PubMed ID: 31332696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
    Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
    J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA MCM3AP-AS1 promotes breast cancer progression via modulating miR-28-5p/CENPF axis.
    Chen Q; Xu H; Zhu J; Feng K; Hu C
    Biomed Pharmacother; 2020 Aug; 128():110289. PubMed ID: 32485570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
    Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
    Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
    Bao G; Huang J; Pan W; Li X; Zhou T
    Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
    Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
    J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.